BIOMAT Database Logo BIOMAT Database Logo

[Neuro-psychiatric evaluation of Clonazepam (Ro 5-4023) in epileptic patients]. 1973

A Caso, and G Raphael-Fernández, and A Romo, and C Martínez, and E Garibay, and J Padilla

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

A Caso, and G Raphael-Fernández, and A Romo, and C Martínez, and E Garibay, and J Padilla
Effect of clonazepam (Ro 5-4023) on epileptic seizures.
January 1973, Acta neurologica Scandinavica. Supplementum,
A Caso, and G Raphael-Fernández, and A Romo, and C Martínez, and E Garibay, and J Padilla
Treatment of epilepsy with clonazepam (Ro 5-4023).
September 1973, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
A Caso, and G Raphael-Fernández, and A Romo, and C Martínez, and E Garibay, and J Padilla
A clinical trial with clonazepam (Ro 5-4023).
January 1973, Acta neurologica Scandinavica. Supplementum,
A Caso, and G Raphael-Fernández, and A Romo, and C Martínez, and E Garibay, and J Padilla
[Clinical use and effect of Ro 5-4023 (clonazepam) in different forms of epileptic seizures].
January 1973, Acta neurologica Scandinavica. Supplementum,
A Caso, and G Raphael-Fernández, and A Romo, and C Martínez, and E Garibay, and J Padilla
[Treatment of the epilepsy using clonazepam (RO 5-4023 - Rivotril)].
January 1972, Rivista di neurobiologia : organo ufficiale della Societa dei neurologi, neuroradiologi e neurochirurghi ospedalieri,
A Caso, and G Raphael-Fernández, and A Romo, and C Martínez, and E Garibay, and J Padilla
Effect of clonazepam (Ro 5-4023) on interictal EEG abnormalities.
January 1973, Acta neurologica Scandinavica. Supplementum,
A Caso, and G Raphael-Fernández, and A Romo, and C Martínez, and E Garibay, and J Padilla
[Clinical trial of Clonazepam (Ro 5-4023 Roche) in the pediatric age].
January 1972, Rivista di neurologia,
A Caso, and G Raphael-Fernández, and A Romo, and C Martínez, and E Garibay, and J Padilla
[Experiences with clonazepam (Ro 5-4023) in the therapy of childhood epilepsy].
October 1974, Fortschritte der Medizin,
A Caso, and G Raphael-Fernández, and A Romo, and C Martínez, and E Garibay, and J Padilla
Clinical experiences with a new anticonvulsant Ro 5-4023 (clonazepam-Rivotrilr).
November 1975, The Journal of the Association of Physicians of India,
A Caso, and G Raphael-Fernández, and A Romo, and C Martínez, and E Garibay, and J Padilla
Clonazepam (Ro 5-4023) in the treatment of myoclonus epilepsy. Four case reports.
January 1973, Acta neurologica Scandinavica. Supplementum,
Copied contents to your clipboard!